Log in
Pharmacology · Cardiovascular Drugs

Pharmacotherapy of acute coronary syndrome

*Syndromum coronarium acutum*

Acute coronary syndrome encompasses conditions ranging from unstable angina to myocardial infarction. Rapid diagnosis and emergency pharmacotherapy aim to relieve pain, stabilize hemodynamics, and restore coronary blood flow.

Main formsST-segment elevation and non-ST-segment elevation
Pain reliefNeuroleptanalgesia, opioids, nitrous oxide
Antiplatelet agentsAcetylsalicylic acid and P2Y12 inhibitors
ThrombolysisOnly in ST-segment elevation
2 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Classification and clinical significance

The term ACS includes variants of unstable angina and myocardial infarction. The introduction of this term is justified by similar clinical manifestations and basic treatment principles, which helps accelerate pre-hospital and in-hospital care.

Clinical forms are divided into two categories:

  • ST-segment elevation: corresponds to the development of transmural myocardial infarction.
  • Non-ST-segment elevation: implies unstable angina or small focal subendocardial infarction. The diagnosis is confirmed by blood necrosis markers — troponins T and I, as well as creatine kinase.

Pain management and hemodynamics

Relief of pain and associated stress at the initial stage is critically important. To achieve this, the following are used:

  • Neuroleptanalgesia (a combination of an opioid analgesic with a neuroleptic, e.g., fentanyl plus droperidol).
  • Opioid analgesics (morphine and analogues).
  • Inhalation anesthesia using a non-opioid analgesic — nitrous oxide.

To control rhythm and hemodynamics, the following are prescribed:

  1. Lidocaine (class IB) — the drug of choice for ventricular extrasystoles, eliminating them without depressing myocardial contractility.
  2. Nitroglycerin (intravenous) — provides hemodynamic unloading and serves as prevention of acute heart failure.
Test your knowledge on the topicTasks from the «Pharmacology» course bank — instant answers and explanations.

Antithrombotic and thrombolytic therapy

Pathogenetic treatment starts in the first hours to prevent thrombus formation:

  • Antiplatelet agents: acetylsalicylic acid, as well as P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor).
  • Direct anticoagulants: heparin (especially in ST elevation), nadroparin calcium, rivaroxaban, dabigatran etexilate. Subsequently, indirect anticoagulants are prescribed to replace direct ones (acenocoumarol, warfarin).

Thrombolytic therapy (fibrinolytics — streptokinase, alteplase) has a strict indication: it is performed exclusively in STEMI (ST-segment elevation acute coronary syndrome) to dissolve fresh thrombi and achieve reperfusion.

Briefly: answers to topical questions

What is the mechanism of action of alteplase during thrombolytic therapy?

  • Alteplase (alteplase) is a recombinant tissue plasminogen activator that acts predominantly within the thrombus structure. The drug activates plasminogen already bound to fibrin strands, providing fibrin-specific activation and localized action.
How to memorize

"ABCD": Aspirin and antiplatelets, Ball-relief/painkillers (opioids/nitrous oxide), Casodilators (nitroglycerin), Deparin (Heparin) and lidocaine.

Class and exam questions

How does ST-elevation ACS differ from the non-elevation form?

The ST-elevation form indicates transmural myocardial infarction and allows for thrombolytic therapy. The non-elevation form implies unstable angina or small focal infarction, confirmed by troponins and creatine kinase.

What medications are used for pain relief in acute coronary syndrome?

Neuroleptanalgesia (fentanyl combined with droperidol), opioid analgesics (morphine), and the inhalation non-opioid anesthetic nitrous oxide are used.

In what cases is thrombolytic therapy prescribed?

Fibrinolytics (e.g., alteplase or streptokinase) are indicated exclusively for patients with ST-segment elevation acute coronary syndrome to dissolve blood clots.

Which antiarrhythmic drug is chosen for ventricular extrasystoles in the acute period?

Lidocaine (class IB) is the drug of choice because it effectively eliminates extrasystoles without depressing myocardial contractility.

Unclear? Ask the AIThe AI tutor has reviewed the material on "Pharmacotherapy of Acute Coronary Syndrome" and will explain it in simple terms.

What else to study on this topic

  • Differential diagnosis of non-ST-elevation ACS using myocardial necrosis markers
  • Mechanisms of action of antiplatelet agents and P2Y12 receptor inhibitors
  • Comparative characteristics of direct and indirect anticoagulants in the acute period
  • Indications and limitations for the use of fibrinolytics in reperfusion therapy
  • The role of neuroleptanalgesia and inhalation anesthetics in reducing cardiac stress
  • Features of symptomatic therapy depending on individual manifestations

Master the entire topic in the «Pharmacology» course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Pharmacotherapy of Acute Coronary Syndrome" and 5,304 more subject pages
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 116 video lessons on the subject

Other topics in the section "Cardiovascular Drugs"

The entire section "Cardiovascular Drugs"

Free video lessons: pharmacologyShort lessons with study notes — no registration required.

Watch lessons

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.